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Dynamic Light Scattering Developed to 
Look Through the Eye's Window Into the 
Body
Dr. Ansari utilizing fiber probe to look into the window of the body.
Microgravity researcher Dr. Rafat R. Ansari, from the NASA Glenn Research Center, has 
found that the eye operates much like a camera and is the "window to the body." The eye 
contains transparent tissue through which light passes, providing us a view of what's going 
on inside. These transparent tissues represent nearly every tissue type that exists 
throughout the body. With the correlations and comparisons of these tissues done at 
Glenn, we hope to improve doctors' ability to diagnose diseases at much earlier stages. 
The medical community will be able to look noninvasively and quantitatively into a 
patient's eyes to detect disease before symptoms appear. Since the eye is easily accessed 
by light, the optical technologies created at Glenn can be used to evaluate its structure and 
physiology in health, aging, and disease.
These efforts have been concentrated into four areas of study: cataracts, diabetes, age-
related macular degeneration (AMD), and Alzheimer's disease. Ophthalmic instruments 
with dynamic light scattering (DLS) capabilities, which were recently developed at Glenn, 
can diagnose cataracts at the molecular level. The fiber-optic probe also can be used for 
the early detection of vitreous diseases, including diabetic retinopathy and asteroid 
hyalosis. In addition, it can monitor blood sugar and cholesterol levels without taking 
blood samples.
Age-related macular degeneration, which damages and destroys the central vision of up to 
one in three people in the United States in their lifetime, has no known cause or cure. It is 
predicted that this disease may soon take on aspects of an epidemic. We hope to detect 
this disease earlier by measuring blood flow through the choroids region in the back of the 
retina and better monitor it with this new technology.
Many of the world's aging population are currently afflicted with Alzheimer's disease. The 
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only current method of diagnosing Alzheimer's is through an autopsy. Brain tissue is 
examined through a microscope to detect a protein substance called amyloid, which is 
deposited in the brains of people with the disease. This research will allow physicians to 
look into the eye tissue for amyloid protein, the same substance found in the Alzheimer's 
patient's brain. If the disease is detected at earlier stages, patients may be helped with anti-
inflammatories, antioxidants, or hormone replacement therapies.
Using helmet-mounted "space-vision" or night vision goggles (similar to those used by F-
16 pilots), doctors will be able to monitor the health of future space travelers and to detect 
cataracts, diabetic retinopathy, Alzheimer's disease, age-related macular degeneration, and 
retinal detachment. The goggles will allow doctors to remotely observe 
electroencephalograms (EEG's) and heart monitors and record body temperatures. This 
apparatus will also assist patients that live in distant areas with limited medical facilities. 
The information gathered through the goggles could be transmitted via satellite to doctors 
and medical personnel at more sophisticated urban medical centers.
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